This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yang R, Tuan RR, Hwang FJ, Bloodgood DW, Kong D, Ding JB. Dichotomous regulation of striatal plasticity by dynorphin. Mol Psychiatry. 2023;28:434–47.
Armbruster DJ, Ueltzhöffer K, Basten U, Fiebach CJ. Prefrontal cortical mechanisms underlying individual differences in cognitive flexibility and stability. J Cogn Neurosci. 2012;24:2385–99.
Genet JJ, Siemer M. Flexible control in processing affective and non-affective material predicts individual differences in trait resilience. Cognition Emot. 2011;25:380–8.
Chen Q, Beaty RE, Wei D, Yang J, Sun J, Liu W, et al. Longitudinal alterations of frontoparietal and frontotemporal networks predict future creative cognitive ability. Cereb Cortex. 2018;28:103–15.
Costa A, Peppe A, Mazzù I, Longarzo M, Caltagirone C, Carlesimo GA. Dopamine treatment and cognitive functioning in individuals with Parkinson’s disease: the “cognitive flexibility” hypothesis seems to work. Behav Neurol. 2014;2014:260896.
Hughes JR. Post-tetanic potentiation. Physiological Rev. 1958;38:91–113.
Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science. 2001;294:1030–8.
Gerfen CR, Engber TM, Mahan LC, Susel ZV, Chase TN, Monsma FJ Jr, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990;250:1429–32.
Zhai S, Tanimura A, Graves SM, Shen W, Surmeier DJ. Striatal synapses, circuits, and Parkinson’s disease. Curr Opin Neurobiol. 2018;48:9–16.
Lee HJ, Weitz AJ, Bernal-Casas D, Duffy BA, Choy M, Kravitz AV, et al. Activation of direct and indirect pathway medium spiny neurons drives distinct brain-wide responses. Neuron. 2016;91:412–24.
Goldstein A, Tachibana S, Lowney LI, Hunkapiller M, Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc Natl Acad Sci. 1979;76:6666–70.
Tejeda HA, Bonci A. Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders. Brain Res. 2019;1713:91–101.
Atwood BK, Kupferschmidt DA, Lovinger DM. Opioids induce dissociable forms of long- term depression of excitatory inputs to the dorsal striatum. Nat Neurosci. 2014;17:540–8.
Shen W, Flajolet M, Greengard P, Surmeier DJ. Dichotomous dopaminergic control of striatal synaptic plasticity. Science. 2008;321:848–51.
Pfeiffer A, Brantl V, Herz A, Emrich HM. Psychotomimesis mediated by κ opiate receptors. Science. 1986;233:774–6.
Tejeda HA, Shippenberg TS, Henriksson R. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. Cell Mol Life Sci. 2012;69:857–96.
Izquierdo A, Brigman JL, Radke AK, Rudebeck PH, Holmes A. The neural basis of reversal learning: an updated perspective. Neuroscience. 2017;345:12–26.
Tejeda HA, Wu J, Kornspun AR, Pignatelli M, Kashtelyan V, Krashes MJ, et al. Pathway-and cell-specific kappa-opioid receptor modulation of excitation-inhibition balance differentially gates D1 and D2 accumbens neuron activity. Neuron. 2017;93:147–63.
Coleman BC, Manz KM, Grueter BA. Kappa opioid receptor modulation of excitatory drive onto nucleus accumbens fast-spiking interneurons. Neuropsychopharmacology. 2021;46:2340–9.
Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D, et al. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci. 2009;106:19168–73.
Knoll AT, Carlezon WA Jr. Dynorphin, stress, and depression. Brain Res. 2010;1314:56–73.
Becker JB, Chartoff E. Sex differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacology. 2019;44:166–83.
Nooyens AC, Wijnhoven HA, Schaap LS, Sialino LD, Kok AA, Visser M, et al. Sex differences in cognitive functioning with aging in the Netherlands. Gerontology. 2022;4:1.
Acknowledgements
The author thanks Dr. Cali A Calarco for constructive feedback. This work was supported by NIH R01DA038613, R01DA047843, and R01MH106500 MKL and the University of Maryland School of Medicine Substance Use in Pregnancy Center.
Author information
Authors and Affiliations
Contributions
JO wrote the commentary’s first draft with input and revisions from MKL. JO and MKL reviewed and approved the final version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Olusakin, J., Lobo, M.K. An endogenous opioid alters neuronal plasticity to constrain cognitive flexibility. Mol Psychiatry 28, 3146–3148 (2023). https://doi.org/10.1038/s41380-023-02204-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-023-02204-x